April 1 2020, David R Brown
New CEO for Swiss-headquartered, Dolder Group
After a quarter-century at the helm of the Dolder Group ("DOLDER"), Dr. Matthys Dolder has handed the company's operations management over to Bruno Crippa as the new CEO. The appointment was effective as from January 1, 2020.
Continuity is important to our family business, which was established in 1898. These changes are a sign of evolution and guarantee that DOLDER will remain a reliable business partner
Dr. Matthys Dolder
Chairman of the Dolder Group
Bruno Crippa is a chemist by education and has been with the Dolder Group for over ten years. He has held the position of Business Unit Manager, Specialty Chemicals and Head of our subsidiaries in Italy, Turkey, and Spain. He is now also a shareholder.
Fifth-generation Dr. Patrick Dolder has joined the Dolder Group's board of directors. He holds a PhD in pharmacy and will certainly contribute new ideas to shape the future development of our enterprise. Dr. Matthys Dolder continues to serve the Group as Chairman of the Board.
“Continuity is important to our family business, which was established in 1898. These changes are a sign of evolution and guarantee that DOLDER will remain a reliable business partner,” said Dr. Matthys Dolder, Chairman of the Dolder Group.
About Dolder Ltd
Dolder AG is a family-owned company specializing in the marketing and distribution of chemical raw materials. Headquartered in Basel, Switzerland, the company is owned by the Dolder family since more than 120 years. Dolder has subsidiaries in Italy, Germany, Spain, and Turkey. Since 2019, B. Bigler AG, a company based in Zug, Switzerland has been supporting the Dolder Group by leveraging the expertise of 85 professionals.
Source(s): Dolder Group Press release
Further Information
Visit: https://www.dolder.com